We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
CRISPR: The new, highly programmable technology shaking up Covid-19 testing
As chief technology officer at Sherlock, Will Blake was part of the team that gained the first ever FDA approval for a CRISRP-based diagnostic kit (Credit: Sherlock Biosciences)